News Agencies Feed

healthcare

Dec 17

Lebanese minister raps removal of ban on pesticides

Public Health Minister Wael Abu Faour fired a warning in response to the agriculture minister’s defense of the decision to lift a ban on previously prohibited agricultural products.

BEIRUT - Public Health"...

Continue Reading >>

Dec 17

Lebanon- Public Health Minister Against Lifting the Ban on Pesticides

Public Health Minister Wael Abu Faour fired a warning Friday in response to the agriculture minister''s Ghazi Zeaiter defense of the decision to lift a ban on previously prohibited agricultural products.

"...

Continue Reading >>

Dec 12

Opinion: Ensuring access to equitable health services, especially during protracted crises

Haifa Hospital, located in a southern suburb of Beirut, Lebanon is operated by the Palestine Red Crescent Society. It is modest in size, with 40 beds, 30 doctors, and 44 nurses who provide primary and secondary health services to an average of 300 inpatients each month and approximately 100 outpatients a day. The patients are mostly Palestinian refugees who fled Palestine after the 1948 Nakba — the Palestinian exodus — and settled in Lebanon. In addition, Haifa Hospital provides its services to Syrian and Palestinian refugees who have fled the conflict in Syria. There are more than 450,000 Palestinian refugees registered and 35,000......

Continue Reading >>

Dec 11

Boehringer Ingelheim Marks Great Progress in Immuno-oncology Research Partnerships in 2017

Boehringer Ingelheim Marks Great Progress in Immuno-oncology Research Partnerships in 2017

2017 marks a year of significant advancement for Boehringer Ingelheim as it secured a range of external partnerships with the goal of transforming the lives of patients and winning the fight against cancer. External partnerships complement Boehringer Ingelheim’s two-pronged research"...

Continue Reading >>

Dec 11

AstraZeneca’s Calquence (acalabrutinib) Shows Potential in Chronic Lymphocytic Leukaemia Trials

AstraZeneca’s Calquence (acalabrutinib) Shows Potential in Chronic Lymphocytic Leukaemia Trials

AstraZeneca and Acerta Pharma, its haematology research and development centre of excellence, today presented results from the Phase Ib/II ACE-CL-003 clinical trial (Abstract #432) and updated results from the Phase I/II ACE-CL-001 (Abstract #498) clinical trial that are testing Calquence"...

Continue Reading >>

Dec 10

Celgene Corporation and bluebird bio Announce Updated Results from Ongoing Multicenter Phase 1 Study of bb2121 Anti-BCMA CAR T Cell Therapy in Patients with Late Stage Relapsed/Refractory Multiple Myeloma at ASH Annual Meeting

Celgene Corporation (NASDAQ: CELG) and bluebird bio, Inc. (Nasdaq: BLUE) today announced that updated results from the ongoing CRB-401 Phase 1 clinical study of bb2121, an investigational anti-B-cell maturation antigen (BCMA) CAR T cell therapy, in 21 patients with late-stage relapsed/refractory multiple myeloma will be presented in an oral presentation at the American Society of Hematology (ASH) Annual Meeting in Atlanta, Georgia. The objective of this Phase 1 dose-escalation study is to evaluate safety and efficacy of bb2121 and determine a recommended Phase 2 dose. “Celgene has a longstanding commitment to patients with multiple myeloma......

Continue Reading >>

Dec 10

NMC Health Ushers In New Era of Healthcare Innovation at 2017 Milken Institute London Summit

NMC Health Ushers In New Era of Healthcare Innovation at 2017 Milken Institute London Summit

Innovations such as artificial intelligence will enable healthcare providers around the world to offer patients a better level of service, the CEO of the region’s leading healthcare groups, NMC Healthcare, has said at a healthcare conference in London.

Speaking"...

Continue Reading >>

Dec 10

Emirates Hospital Advances Breast Cancer Care with New Sentimag® Technology

Emirates Hospital Advances Breast Cancer Care with New Sentimag® Technology

Emirates Hospital, a subsidiary of Emirates Healthcare and located in Dubai, has become the first healthcare facility in the UAE to acquire Sentimag®, an innovative medical device that greatly improves a clinician’s ability to precisely diagnose breast cancer. It also helps the"...

Continue Reading >>

Dec 10

Mommies Gather for a Meet and Interact Session Held by Cosmesurge

Mommies Gather for a Meet and Interact Session Held by Cosmesurge

CosmeSurge, a subsidiary of Emirates Healthcare, in association with CPI Media Group held a meet and interact session titled ‘Mother Baby & Child Mama’s Morning’ for seasoned and new mums. Held at Burj Al Arab on December"...

Continue Reading >>

Dec 08

Neustar Launches Next Generation DDoS Defense Network: SiteProtect NG™

Neustar Launches Next Generation DDoS Defense Network: SiteProtect NG™

Neustar, Inc., a trusted, neutral provider of real-time information services, today launched SiteProtect NG™ (Next Generation), its new solution to protect brands against DDoS (distributed denial of service) attacks. It is the latest wave of the company’s purpose-built DDoS mitigation solution designed to meet the security requirements of all brands, on-premise and in the cloud, to deal with the next generation of cyber threats. This powerful upgrade adds Neustar’s state of the art WAF (web application firewall) solution to the award-winning Neustar SiteProtect solution to extend network protection to the application layer.......

Continue Reading >>